MARKET

LGNYZ

LGNYZ

Ligand Pharma
OTCPK
0.035
NaN%
Closed 09:30 05/15 EDT
OPEN
--
PREV CLOSE
0.035
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.066
52 WEEK LOW
0.0030
MARKET CAP
--
P/E (TTM)
-0.1593
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LGNYZ last week (0505-0509)?
Weekly Report · 3d ago
LIGAND PHARMACEUTICALS INCORPORATED Quarterly Report
Press release · 6d ago
Ligand Pharmaceuticals sees 22% CAGR in royalty revenue through 2029
Seeking Alpha · 05/08 18:20
Weekly Report: what happened at LGNYZ last week (0428-0502)?
Weekly Report · 05/05 11:29
Weekly Report: what happened at LGNYZ last week (0421-0425)?
Weekly Report · 04/28 11:39
Weekly Report: what happened at LGNYZ last week (0414-0418)?
Weekly Report · 04/21 11:39
Weekly Report: what happened at LGNYZ last week (0407-0411)?
Weekly Report · 04/14 11:27
Weekly Report: what happened at LGNYZ last week (0331-0404)?
Weekly Report · 04/07 11:27
More
About LGNYZ
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.

Webull offers Ligand Pharmaceuticals Inc stock information, including OTCPK: LGNYZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGNYZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGNYZ stock methods without spending real money on the virtual paper trading platform.